Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Alexandra Walsh Named Law 360 Trials MVP of the Year

WASHINGTON – Wilkinson Walsh Founding Partner Alexandra Walsh was named one of Law360’s 2019 Trial MVPs of the Year. The award recognizes Walsh for leading “trial teams to a string of crucial victories for Bayer AG this year, persuading juries to reject a certified class action attacking the company’s One A Day vitamins as well as suits over its blood thinner Xarelto.”

Wilkinson Walsh Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Walsh is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Walsh’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Walsh won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Walsh, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Walsh, led by Kosta Stojilkovic …

Law360 MVP: Wilkinson Walsh’s Beth Wilkinson

Law360, New York — Wilkinson Walsh & Eskovitz PLLC’s Beth Wilkinson only co-founded her firm a year ago, and she and her team have already scored major victories defending Georgia Pacific from a $10 billion antitrust suit and winning the first two trials in the high-stakes Xarelto litigation, securing her a place as one of Law360’s 2017 Trials MVPs. The story is available here. Her biggest accomplishment this year: Wilkinson said that despite the many trial and motion victories her young firm has notched up this past year, her biggest accomplishment is undoubtedly the founding of Wilkinson Walsh itself back in January. “The building of our firm and the incredibly talented people we’ve managed to get together to work on these cases has been nothing short of amazing,” Wilkinson said. “We started with 17 lawyers and now we’re at 40, and we’re already taking on big, bet-the-company cases that people normally think only BigLaw can …

Law360: Litigation Boutiques Match, Exceed Cravath Scale Bonuses

Law360, New York (December 5, 2017, 6:28 PM EST) — A pair of litigation boutiques have revealed that their associates would receive year-end bonuses that either matched or exceeded the market scale established by Cravath Swaine & Moore LLP, which has remained the standard among many BigLaw firms. Holwell Shuster & Goldberg LLP announced that its associate bonuses would align with the so-called Cravath scale, ranging from $15,000 to $100,000, while Wilkinson Walsh & Eskovitz LLP, as it did last year, offered bonuses that exceeded that scale by 50 percent for all associates across the board, according to memos that were initially made public Tuesday on legal news blog Above The Law and whose authenticity was confirmed to Law360. “As in the past, this year we remain committed to recognizing the contributions of our excellent associates,” Wilkinson Walsh partners said in their memo. “And, we are fortunate again this year to be able to provide bonus compensation …

Beth Wilkinson Named American Lawyer’s Litigator of the Week and a Law360 Legal Lion for Win in Bellwether Trial for Bayer’s Xarelto

WASHINGTON, May 5, 2017 – Beth Wilkinson was named American Lawyer’s Litigator of the Week and a Law360 Legal Lion. The accolades come after Beth successfully led a team of lawyers in defense of Bayer Healthcare Pharmaceuticals in a key bellwether trial over the blood thinner Xarelto. A federal jury in New Orleans deliberated for about one hour before unanimously deciding in favor of Bayer. On the victory, Wilkinson said, “If you can make your case really clear, so the jury from opening to closings knows what you’re saying, it makes it easier to go back and come to a consensus.” “When doctors come in and say this medication works and is important, it makes it very difficult for plaintiffs to prevail.” Wilkinson will stay on as lead counsel in the next Xarelto trial in New Orleans, scheduled for May 30. Beth Wilkinson is a founding partner at Wilkinson Walsh. …

Bond Behind Trial Firm Wilkinson Walsh Forged By Garland

Law360, New York (March 16, 2016, 9:04 PM ET) — One morning in 2014, in a Boston courtroom, Beth Wilkinson stood facing a witness that she wasn’t ready for. The witness had prepped with her partner, Alexandra Walsh, whose seat sat empty next to her. At that moment, Walsh was sick in a hotel room, waiting for an emergency doctor to arrive. “She couldn’t talk; she couldn’t even sit in the courtroom,” Wilkinson said. “It was horrible,” Walsh said. They had been hired just three weeks before by entrepreneur Michael Rubin, whose GSI Commerce was being… Read the full article at www.law360.com